Dartmouth College, via the Trustees of Dartmouth College, disclosed a new position in BlackRock’s iShares Bitcoin Trust ETF (IBIT), reporting 201,531 shares worthDartmouth College, via the Trustees of Dartmouth College, disclosed a new position in BlackRock’s iShares Bitcoin Trust ETF (IBIT), reporting 201,531 shares worth

Ivy League Money Buys Bitcoin And Ethereum: Dartmouth Discloses IBIT, ETH Mini Stakes

Dartmouth College, via the Trustees of Dartmouth College, disclosed a new position in BlackRock’s iShares Bitcoin Trust ETF (IBIT), reporting 201,531 shares worth $10,006,014 as of Dec. 31, 2025, according to a Form 13F filed on Jan. 14. The same filing also shows a fresh allocation to the Grayscale Ethereum Mini Trust, a rare double-print of BTC and ETH exposure inside an Ivy League endowment’s public equity book.

Dartmouth’s Endowment Adds Bitcoin And Ethereum

Crypto market observers flagged the disclosure immediately. MacroScope, an analyst account that tracks institutional positioning, framed the filing as a meaningful signal from the endowment complex: “Very important filing today. In a 13F, Dartmouth College reported owning 201,531 shares of IBIT as of December 31, valued over $10 million. It also reported owning 178,148 shares of Grayscale Ethereum Mini valued at $4.9 million.”

The SEC filing provides the precise marks. Dartmouth’s Grayscale Ethereum Mini Trust stake was listed at $4,998,833 for 178,148 shares at quarter-end, placing the combined Bitcoin and Ethereum allocations at roughly $15.0 million of reported 13F holdings.

In the context of Dartmouth’s disclosed 13F portfolio, crypto remains a slice rather than a core. The filing’s summary page lists a “Form 13F Information Table Value Total” of $393,306,686 across nine positions. On that math, IBIT represents about 2.5% of the reported book, with the Ethereum Mini position adding roughly 1.3%.

The rest of the holdings read like a traditional endowment liquid sleeve. Dartmouth’s largest position was SPDR S&P 500 ETF Trust at $227,897,664, alongside sizable allocations to emerging markets (iShares Core MSCI Emerging Markets at $50,043,811), a quality-factor ETF (GMO US Quality at $42,153,006), and a value ETF (Vanguard Value at $34,807,928).

Notably, neither IBIT nor the Grayscale Ethereum Mini Trust appeared in Dartmouth’s prior 13F for the quarter ended Sept. 30, 2025, supporting the claim that both positions were new additions heading into year-end. Notably, Dartmouth is not the first campus allocator to route crypto exposure through the ETF wrapper. Brown University disclosed a new IBIT position in its March 31, 2025 13F, 105,000 shares valued around $4.9 million, the school’s “first foray” into spot bitcoin ETF ownership that quarter.

Emory University moved earlier. In an October 2024 disclosure, the Atlanta-based school reported putting $15.8 million from its endowment into a publicly traded bitcoin ETF, with the filing showing roughly 2.7 million shares of Grayscale’s Bitcoin Mini Trust.

And at the other end of the spectrum sits Harvard’s endowment manager. Harvard Management Co.’s public-equities 13F for the quarter ended Sept. 30, 2025 showed IBIT as its largest reported position, 6,813,612 shares worth about $442.9 million on the filing’s valuation marks.

At press time, Bitcoin traded at $96,284.

Bitcoin price chart
Market Opportunity
Intuition Logo
Intuition Price(TRUST)
$0.109
$0.109$0.109
-2.76%
USD
Intuition (TRUST) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Over $145M Evaporates In Brutal Long Squeeze

Over $145M Evaporates In Brutal Long Squeeze

The post Over $145M Evaporates In Brutal Long Squeeze appeared on BitcoinEthereumNews.com. Crypto Futures Liquidations: Over $145M Evaporates In Brutal Long Squeeze
Share
BitcoinEthereumNews2026/01/16 11:35
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Edges higher ahead of BoC-Fed policy outcome

Edges higher ahead of BoC-Fed policy outcome

The post Edges higher ahead of BoC-Fed policy outcome appeared on BitcoinEthereumNews.com. USD/CAD gains marginally to near 1.3760 ahead of monetary policy announcements by the Fed and the BoC. Both the Fed and the BoC are expected to lower interest rates. USD/CAD forms a Head and Shoulder chart pattern. The USD/CAD pair ticks up to near 1.3760 during the late European session on Wednesday. The Loonie pair gains marginally ahead of monetary policy outcomes by the Bank of Canada (BoC) and the Federal Reserve (Fed) during New York trading hours. Both the BoC and the Fed are expected to cut interest rates amid mounting labor market conditions in their respective economies. Inflationary pressures in the Canadian economy have cooled down, emerging as another reason behind the BoC’s dovish expectations. However, the Fed is expected to start the monetary-easing campaign despite the United States (US) inflation remaining higher. Investors will closely monitor press conferences from both Fed Chair Jerome Powell and BoC Governor Tiff Macklem to get cues about whether there will be more interest rate cuts in the remainder of the year. According to analysts from Barclays, the Fed’s latest median projections for interest rates are likely to call for three interest rate cuts by 2025. Ahead of the Fed’s monetary policy, the US Dollar Index (DXY), which tracks the Greenback’s value against six major currencies, holds onto Tuesday’s losses near 96.60. USD/CAD forms a Head and Shoulder chart pattern, which indicates a bearish reversal. The neckline of the above-mentioned chart pattern is plotted near 1.3715. The near-term trend of the pair remains bearish as it stays below the 20-day Exponential Moving Average (EMA), which trades around 1.3800. The 14-day Relative Strength Index (RSI) slides to near 40.00. A fresh bearish momentum would emerge if the RSI falls below that level. Going forward, the asset could slide towards the round level of…
Share
BitcoinEthereumNews2025/09/18 01:23